FTC:WATCH No. 587 (2002-8)
April 22, 2002
Washington, D.C.
IN THIS ISSUE
Biovail must dismiss patent suit
Rx industry antitrust red flags
Anthony on dietary supplement claims
Public comments on disgorgement
Leary on "Clinical Integration"...
Washington, D.C.
IN THIS ISSUE
Biovail must dismiss patent suit
Rx industry antitrust red flags
Anthony on dietary supplement claims
Public comments on disgorgement
Leary on "Clinical Integration"...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this contentIf you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch
